Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
510 Leser
Artikel bewerten:
(2)

International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries

The partnership will enhance diabetes care through training aimed at building capacity among healthcare professionals in low and middle-income countries.

BRUSSELS, Jan. 16, 2024 /PRNewswire/ -- The International Diabetes Federation (IDF), in collaboration with Sanofi's Global Health Unit (GHU), is taking significant steps to improve access to diabetes care. The collaboration aims to support the early diagnosis, management and prevention of diabetes and its complications by training a minimum of 4,000 healthcare professionals (HCPs) in low and middle-income countries (LMICs) under-prepared to address the growing number of people living with diabetes.

The partnership will enhance the diabetes knowledge and skills of HCPs, particularly primary care physicians, nurses, diabetes educators and pharmacists in 40 countries.

According to the IDF Diabetes Atlas, the majority of the more than half a billion individuals now living with diabetes worldwide are found in LMICs. This number is predicted to reach 783 million by 2045, with 94% of the total increase occurring in LMICs - a total of 233 million more people with diabetes. Consequently, there is an increasing need for diabetes-trained healthcare professionals in these countries to help lead the response.

Compared to other regions, the highest proportionate increase in the number of people with diabetes by 2045 is predicted to occur in Sub-Saharan Africa, with a 129% increase expected. The region will be a significant area of focus for the partners during the first phase of the programme. The collaboration between IDF and GHU consists of the following key components:

  • Online training for 1,500 HCPs in 40 target countries.
  • Face-to-face training for 2,500 HCPs in five carefully selected countries.
  • Courses delivered in English and French.

The selection process for participants has started. Ministries of Health, national diabetes associations and scientific societies have already identified more than 500 healthcare professionals to take part in the training. The five countries selected for the face-to-face training are Cambodia, Chad, Malawi, Togo, and Uganda.

Professor Akhtar Hussain, President of the International Diabetes Federation, said: "We believe that access to quality diabetes care is a fundamental right for everyone living with diabetes, regardless of where they live. This collaboration with Sanofi's Global Health Unit marks a significant step towards realising our vision. By equipping healthcare professionals in under-served regions with the necessary knowledge and skills, we are not only transforming lives, but are also helping build a stronger global response to the threat diabetes currently poses to countries and communities."

"Sanofi's Global Health Unit is committed to ensuring access to affordable, equitable and sustainable healthcare in 40 of the most vulnerable countries around the world. Cross-sector partnerships, like this collaboration with IDF; are critical to achieving our shared mission to combat diabetes on a global scale. By empowering healthcare professionals with the latest knowledge and skills, we are working together to make a tangible difference in the lives of those affected by diabetes," added Jon Fairest, Head of Global Health Unit, Sanofi.

IDF and Sanofi's GHU recognise that achieving early diagnosis and equitable access to ongoing diabetes care require a collective effort, involving local and national health systems, inter-governmental agencies, and civil society.

For more information about this joint initiative, please visit www.idfdiabeteschool.org/ghu-training/en

About The International Diabetes Federation
The International Diabetes Federation (IDF) is an umbrella organisation of over 240 national diabetes associations in 160 countries and territories. Its mission is to improve the lives of people with diabetes and prevent diabetes in those at risk. The Federation has been leading the global diabetes community since 1950. www.idf.org

Cision View original content:https://www.prnewswire.co.uk/news-releases/international-diabetes-federation-and-sanofi-global-health-unit-collaborate-to-strengthen-diabetes-response-in-40-countries-302034981.html

© 2024 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.